{
  "docId": "019de070-3657-744f-8469-a4294fbedcbe",
  "docSlug": "17e3f38e05c3dcb59be9aebb9723e39c",
  "documentTitle": "Relay Therapeutics | IPO Presentation Deck | 25 slides",
  "authorId": "relay-therapeutics",
  "authorName": "Relay Therapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2020-07-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 21,
  "pageCount": 25,
  "prevPage": 20,
  "nextPage": 22,
  "slideType": "traction",
  "function": "show_traction",
  "density": "dense",
  "nDataPoints": 2,
  "notes": "The slide uses a before-after-framing style to contrast efficacy and side-effect profiles.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-3657-744f-8469-a4294fbedcbe/21",
  "deckHref": "/decks/019de070-3657-744f-8469-a4294fbedcbe",
  "deckJsonHref": "/decks/019de070-3657-744f-8469-a4294fbedcbe.json",
  "deckAnchorHref": "/decks/019de070-3657-744f-8469-a4294fbedcbe#slide-21",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.4,
        "x": 0.55,
        "y": 0.15
      },
      "kind": "callout",
      "text": "...With minimal increases in serum insulin levels for Relay Tx Compound",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "34c8da8c-3fb4-4e1c-a6cd-9b1835013604",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.4,
        "x": 0.05,
        "y": 0.15
      },
      "kind": "callout",
      "text": "Significant anti-tumor activity in PI3K mutant mouse xenograft model...",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f79672b3-9eb3-47a6-af41-fc97333e18cc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.4,
        "x": 0.55,
        "y": 0.25
      },
      "kind": "chart",
      "text": "Insulin Response",
      "attrs": null,
      "subkind": "bar-grouped",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c0108c2f-571b-41ea-ad21-9e30abdde4e1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.45,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "chart",
      "text": "CAL33 Tumor Growth",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "66c72753-d39a-4cac-ba56-8eec3fc143b4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.65,
        "x": 0.3,
        "y": 0.85
      },
      "kind": "legend",
      "text": "Vehicle, Alpelisib (50mpk QD), Alpelisib (12.5mpk QD), RLY-PI3K1047 (100mpk BID), RLY-PI3K1047 (50mpk BID)",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2def51c9-ec9e-4f53-a651-a4952f25eaa3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.7,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "PI3Kα – In Vivo Tumor Growth Inhibition With Minimal Increases in Insulin Levels",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0419a09d-73bb-4de3-8f09-94a1739c5eba",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "before-after-framing",
      "slug": null,
      "matchId": "1d15fd2d-6b3b-4aad-bc42-af54377a82e5",
      "evidence": "Contrasting tumor growth (efficacy) with insulin levels (side effects) to demonstrate superiority.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}